A new therapy based on embryonic stem cells will give a new hope to people who did lose their ability to move in some accident. But that’s not all, because this therapy, developed by the Geron Corp., is the demonstration that in USA, since a few days from Obama‘s election, a new course in research – above all in stem cells research – has begun.
The Food and Drug Administration (FDA) frees the medics to inject spinal stem cells extracted from embryonic tissue in legs paralysed patients since a short time. The treatment in on experimental phase, but stem cells should stimulate damaged nerves to grow.
The goal is to re-activate the spinal marrow normal functions. Unfortunately it’s not so operative for patients paralysed sinc more than 1 or 2 weeks.
Geron’s whole work is funded by private; at present no public funding are planned in this field due to Bush‘s 2006 veto, despite the United States Congress gives the go-ahead.
The fact that FDA did not oppose to this, although it’s an indipendent organization, suggests that something is changing.